Mission Ax-2 set to launch stem cells to space

A Phase II study led by Cedars-Sinai demonstrates that a monoclonal antibody treatment is safe and effective at helping people with moderate to severe ulcerative colitis reach clinical remission. The therapy targets TL1A, a protein that contributes to the severity of the disease.

The ESA Hera mission is set to launch in just under a month, with representatives discussing the mission's expectations and current status. The BepiColombo Mission to Mercury is also being updated following its successful flyby, with insights into previous flybys and plans for the remainder of the mission.

Researchers at Mount Sinai discovered a technique to renew aged blood-forming stem cells by correcting defects in lysosomes. The breakthrough revealed that restoring lysosomal slow degradation can revitalize aged stem cells and enhance their regenerative capacity. This study may help prevent age-related blood disorders and improve stem...

Researchers at Cedars-Sinai Medical Center have identified a mechanism that could help treat patients with spinal cord injuries, stroke, and neurological conditions. Astrocytes, a type of cell in the central nervous system, play a critical role in responding to damage and disease, sending signals to immune cells to clean up debris resu...

Researchers at Cedars-Sinai created a lifelike model of motor neurons that die in patients with ALS, allowing them to detect differences between healthy and diseased cells. The study suggests that excessive glutamate signaling may be a contributing factor to the disease.

Researchers at Cedars-Sinai Medical Center have discovered that gut bacteria produce nicotinic acid, a molecule that activates a protective mechanism in colon cells, reducing the risk of tissue injury and disease. This finding has important implications for understanding how intestinal disorders, such as Crohn's disease, develop.